In Coalition, ASAM Asks House Appropriations to Uphold Tobacco Fees and Oppose Weakening FDA Authority in Related Bill Markup

ASAM signed a letter sent to the leadership of the House Appropriations Committee, urging their approval of the full authorized level of tobacco user fees, and that they oppose any efforts to weaken or alter the Food and Drug Administration's (FDA) authority over tobacco products in the appropriations process. The Committee will soon mark up the related Fiscal Year 2025 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations bill.

Read the letter here.